TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

25.50$ +0.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVLN
Line item Q1 26 Q2 26
100.0% 100.0%
95.8% 84.1%
68.0% 62.1%
90.8% 82.8%
0.2% 0.4%
294.8% 6.4%
8.7% 2.5%
0.4% 0.2%
2.3% 0.6%
10.9% 3.5%
-194.8% 93.6%
-215.4% -75.5%
30.8% 10.4%

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?